Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Benefit–risk assessment of rivaroxaban versus...
Journal article

Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty

Abstract

PURPOSE: Venous thromboembolism is a common complication after major orthopedic surgery. When prescribing anticoagulant prophylaxis, clinicians weigh the benefits of thromboprophylaxis against bleeding risk and other adverse events. Previous benefit-risk analyses of the REgulation of Coagulation in ORthopaedic surgery to prevent Deep vein thrombosis and pulmonary embolism (RECORD) randomized clinical studies of rivaroxaban versus enoxaparin …

Authors

Levitan B; Yuan Z; Turpie AG; Friedman RJ; Homering M; Berlin JA; Berkowitz SD; Weinstein RB; DiBattiste PM

Journal

Vascular Health and Risk Management, Vol. 10, No. 0, pp. 157–167

Publisher

Taylor & Francis

Publication Date

March 26, 2014

DOI

10.2147/vhrm.s54714

ISSN

1176-6344